MedPath

A CLINICAL TRIAL TO STUDY THE EFFECT OF PATHADI CHURNA IN FUNGAL INFECTION OF SKI

Phase 2
Conditions
Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
Registration Number
CTRI/2021/01/030238
Lead Sponsor
Dean Faculty of Ayurved Parul University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients having clinical signs like kandu, raga, mandala, pidika.

Patients of all varieties of Tinea will be included irrespective of area of infection. Viz., Tinea â??corporis, crusis, capitis, pedis,

manuum, except tinea unguium, tinea barbae .

Chronicity not more than 1 year.

Exclusion Criteria

patient having Tinea unginum, tinea barbae.

K/C/o Uncontrolled Hypertension & Diabetes Melitus.

Pregnant and lactating Women.

k/c/o of immunocompromised subjects & autoimmune cases.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Effect on symptoms of dadru <br/ ><br>Effect on KOH Test in each group of 4 patientsTimepoint: Effect on symptoms of dadru at baseline and at the end of every 15 days till 60 days. <br/ ><br>Effect on KOH Test in each group of 4 patients at baseline and at the end of 60 days.
Secondary Outcome Measures
NameTimeMethod
Itching (kandu) <br/ ><br> Inflammation (pidika) <br/ ><br>Color changes(raga) <br/ ><br> Nature of lesion (mandalas) <br/ ><br> Size of lesion(size of mandalas) No.of lesion (no.of mandalas) <br/ ><br> No.of lesions (no. of mandalas)1. 5-D Pruritus scale <br/ ><br>2. Dermatology life quality index (DLQI). <br/ ><br>3. Photographic evidence.Timepoint: Effect on symptoms at baseline and at the end of every 15 days till 60 days.
© Copyright 2025. All Rights Reserved by MedPath